NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 13D/13G Filings for Eagle Pharmaceuticals, Inc. (EGRX)

NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 13D and 13G filings for Eagle Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-19
4:32 pm
Purchase
2025-02-1613GEagle Pharmaceuticals, Inc.
EGRX
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP810,630
6.241%
810,630increase
(New Position)
Filing